These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1295443)

  • 1. p53 mutation in human nasopharyngeal carcinomas.
    Lo KW; Mok CH; Huang DP; Liu YX; Choi PH; Lee JC; Tsao SW
    Anticancer Res; 1992; 12(6B):1957-63. PubMed ID: 1295443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of p53 gene mutations in primary nasopharyngeal carcinomas.
    Spruck CH; Tsai YC; Huang DP; Yang AS; Rideout WM; Gonzalez-Zulueta M; Choi P; Lo KW; Yu MC; Jones PA
    Cancer Res; 1992 Sep; 52(17):4787-90. PubMed ID: 1511442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presence of p53 mutations in primary nasopharyngeal carcinoma (NPC) in non-Asians of Los Angeles, California, a low-risk population for NPC.
    Van Tornout JM; Spruck CH; Shibata A; Schmutte C; Gonzalez-Zulueta M; Nichols PW; Chandrasoma PT; Yu MC; Jones PA
    Cancer Epidemiol Biomarkers Prev; 1997 Jul; 6(7):493-7. PubMed ID: 9232335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational analysis of p53 and RB2/p130 genes in Malaysian nasopharyngeal carcinoma samples: a preliminary report.
    Hoe SL; Sam CK
    Malays J Pathol; 2006 Jun; 28(1):35-9. PubMed ID: 17694957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A hot-spot mutation of p53 gene in nasopharyngeal carcinoma].
    Chen R; Zhu D; Yin W
    Zhonghua Zhong Liu Za Zhi; 1995 Nov; 17(6):401-4. PubMed ID: 8697986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection.
    Fujita M; Inoue M; Tanizawa O; Iwamoto S; Enomoto T
    Cancer Res; 1992 Oct; 52(19):5323-8. PubMed ID: 1327506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presence of p53 mutation in human cervical carcinomas associated with HPV-33 infection.
    Lo KW; Mok CH; Chung G; Huang DP; Wong F; Chan M; Lee JC; Tsao SW
    Anticancer Res; 1992; 12(6B):1989-94. PubMed ID: 1363512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma.
    Zhong BL; Zong YS; Lin SX; Zhang M; Liang YJ
    Ai Zheng; 2006 Feb; 25(2):136-42. PubMed ID: 16480574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of heterozygosity and its correlation with clinical outcome and Epstein-Barr virus infection in nasopharyngeal carcinoma.
    Shao JY; Huang XM; Yu XJ; Huang LX; Wu QL; Xia JC; Wang HY; Feng QS; Ren ZF; Ernberg I; Hu LF; Zeng YX
    Anticancer Res; 2001; 21(4B):3021-9. PubMed ID: 11712805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High frequency loss of heterozygosity on the long arms of chromosomes 13 and 14 in nasopharyngeal carcinoma in Southern China.
    Shao J; Li Y; Wu Q; Liang X; Yu X; Huang L; Hou J; Huang X; Ernberg I; Hu LF; Zeng Y
    Chin Med J (Engl); 2002 Apr; 115(4):571-5. PubMed ID: 12133301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein Barr virus associated pediatric nasopharyngeal carcinoma: its correlation with p53 and bcl-2 expression.
    Preciado MV; Chabay PA; De Matteo EN; Gismondi MI; Rey G; Zubizarreta P
    Med Pediatr Oncol; 2002 May; 38(5):345-8. PubMed ID: 11979459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of E-cadherin and beta-catenin with metastasis in nasopharyngeal carcinoma.
    Li Z; Ren Y; Lin SX; Liang YJ; Liang HZ
    Chin Med J (Engl); 2004 Aug; 117(8):1232-9. PubMed ID: 15361301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of seven newly established nasopharyngeal carcinoma cell lines.
    Lin CT; Chan WY; Chen W; Huang HM; Wu HC; Hsu MM; Chuang SM; Wang CC
    Lab Invest; 1993 Jun; 68(6):716-27. PubMed ID: 7685844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
    Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H
    Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p16 gene alterations in nasopharyngeal carcinoma.
    Lo KW; Huang DP; Lau KM
    Cancer Res; 1995 May; 55(10):2039-43. PubMed ID: 7743498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mutation and expression of SEMA3B and SEMA3F gene in nasopharyngeal carcinoma].
    Liu XQ; Sun M; Chen HK; Li JX; Pan ZG; Long QX; Wang XZ; Zeng YX
    Ai Zheng; 2003 Jan; 22(1):16-20. PubMed ID: 12561429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A lack of association between p53 mutations and recurrent nasopharyngeal carcinomas refractory to radiotherapy.
    Chang KP; Hao SP; Lin SY; Tsao KC; Kuo TT; Tsai MH; Tseng CK; Tsang NM
    Laryngoscope; 2002 Nov; 112(11):2015-9. PubMed ID: 12439172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No point mutation but decreased expression of the p16/MTS1 tumor suppressor gene in nasopharyngeal carcinomas.
    Sun Y; Hildesheim A; Lanier AE; Cao Y; Yao KT; Raab-Traub N; Yang CS
    Oncogene; 1995 Feb; 10(4):785-8. PubMed ID: 7862458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 mutational spectrum of esophageal carcinomas from five different geographical locales in China.
    Lung ML; Chan WC; Zong YS; Tang CM; Fok CL; Wong KT; Chan LK; Lau KW
    Cancer Epidemiol Biomarkers Prev; 1996 Apr; 5(4):277-84. PubMed ID: 8722219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of transcripts initiated from two viral promoters (Cp and Wp) in Epstein-Barr virus-infected nasopharyngeal carcinoma cells and biopsies.
    Chang Y; Sheen TS; Lu J; Huang YT; Chen JY; Yang CS; Tsai CH
    Lab Invest; 1998 Jun; 78(6):715-26. PubMed ID: 9645762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.